Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
Public ClinicalTrials.gov record NCT05224258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This global study (US, Canada, and Australia) will evaluate the safety and effectiveness of the MiniMed 780G system in type 1 adult and pediatric subjects utilizing Fiasp (insulin aspart injection) in a home setting.
Study identification
- NCT ID
- NCT05224258
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2022 (Actual)
- Primary completion
- Jun 21, 2024 (Actual)
- Completion
- Jun 21, 2024 (Actual)
- Last update posted
- Jun 22, 2025
2022 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Investigations, Inc. | Little Rock | Arkansas | 72211 | — |
| Valley Research | Fresno | California | 93720 | — |
| Sutter Institute for Medical Research | Sacramento | California | 95821 | — |
| Rady's Children's Hospital | San Diego | California | 92123 | — |
| Barbara Davis Center for Diabetes | Aurora | Colorado | 80045 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| Endocrine Research Solutions | Roswell | Georgia | 30076 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| Barry J Reiner MD, LLC | Baltimore | Maryland | 21229 | — |
| The Docs, LLC | Las Vegas | Nevada | 89113 | — |
| Physicians East | Greenville | North Carolina | 27834 | — |
| Diabetes and Glandular Disease Clinic, P.A. | San Antonio | Texas | 78229 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05224258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05224258 live on ClinicalTrials.gov.